- ►diabetesjournals.org … JG Regensteiner, H Vlassara, JEB Reusch - Diabetes Care, 2006 - Am Diabetes Assoc The morbidity caused by diabetes has traditionally been classified into macro-
and microvascular complications. Although macrovascular complications have
received greater attention, microvascular complications are unique to ... Cited by 41 - Related articles - All 6 versions
- ►endojournals.org SY Goh, ME Cooper - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Evidence Synthesis: In this review we report on how these AGEs may exert
deleterious effects in diabetes, as well as address current strategies to
interrupt the formation or action of AGEs. First, AGEs act directly to ... Cited by 42 - Related articles - BL Direct - All 4 versions
- ►nih.gov IG Obrosova, VR Drel, P Pacher, O Ilnytska, … - Diabetes, 2005 - Am Diabetes Assoc Poly(ADP-ribose) polymerase (PARP) activation, an important factor in the
pathogenesis of diabetes complications, is considered a downstream effector of
oxidative-nitrosative stress. However, some recent findings suggest that it ... Cited by 37 - Related articles - BL Direct - All 11 versions
- ►diabetesjournals.org C Szabó, A Biser, R Benkő, E Böttinger, K … - Diabetes, 2006 - Am Diabetes Assoc The activation of the poly(ADP-ribose) polymerase (PARP) plays an important role
in the pathophysiology of various diseases associated with oxidative stress. We
found increased amounts of poly(ADP) ribosylated proteins in diabetic ... Cited by 35 - Related articles - BL Direct - All 6 versions
- ►nih.gov O Ilnytska, VV Lyzogubov, MJ Stevens, VR … - Diabetes, 2006 - Am Diabetes Assoc Poly(ADP-ribose) polymerase (PARP) activation is emerging as a fundamental
mechanism in the pathogenesis of diabetes complications including diabetic
neuropathy. This study evaluated the role of PARP in diabetic sensory ... Cited by 26 - Related articles - BL Direct - All 10 versions
- ►aspetjournals.org MJ Stevens, F Li, VR Drel, OI Abatan, H Kim, … - Journal of Pharmacology and Experimental …, 2007 - ASPET In diabetes, activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP)
is an important effector of oxidative-nitrosative injury, which contributes to
the development of experimental diabetic peripheral neuropathy (DPN). ... Cited by 21 - Related articles - All 7 versions
DW Zochodne - Muscle and Nerve, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 15 - Related articles - BL Direct - All 4 versions
VR Drel, P Pacher, I Vareniuk, I Pavlov, O … - European journal of pharmacology, 2007 - pubmedcentral.nih.gov Whereas an important role of free radicals and oxidants in peripheral diabetic
neuropathy is well established, the contribution of nitrosative stress and, in
particular, of the highly reactive oxidant peroxynitrite, has not been ... Cited by 13 - Related articles - All 6 versions
C Figueroa-Romero, M Sadidi, EL Feldman - Reviews in Endocrine & Metabolic Disorders, 2008 - Springer Abstract Diabetic neuropathy is the most common com- plication of diabetes,
affecting 50% of diabetic patients. Currently, the only treatment for diabetic
neuropathy is glucose control and careful foot care. In this review, we ... Cited by 11 - Related articles - All 2 versions
R Olszanecki, A Gebska, J Jawien, A … - Journal of physiology and pharmacology, 2006 - jpp.krakow.pl Activation of both poly (ADP-ribose) polymerase (PARP) and inducible nitric
oxide synthase (NOS-2) have been implicated in the pathogenesis of various forms
of inflammation, therefore compounds which may simultaneously inhibit both ... Cited by 9 - Related articles - Cached - BL Direct - All 7 versions
